Skip to main content

US Drug Prices — Medicare Part D Spending

US drug prices, on these pages, mean the average Medicare Part D spending per dosage unit — the amount the Medicare Part D program spent, on average, per billing unit (e.g. one tablet) of a drug in calendar year 2024, across all manufacturers. Figures come from real CMS open data, in US dollars ($), for the 100 highest-volume Part D drugs. They are not pharmacy cash prices and not medical advice.

How much do the most common US drugs cost, and what does the figure mean?

Across the 100 highest-volume Medicare Part D drugs (calendar year 2024, CMS open data), average Medicare spending per dosage unit ranges from $0.0564 (Metformin HCl) to $511.63 (Mounjaro). The most-claimed is Atorvastatin Calcium at $0.1452 per unit. This is Medicare program spending, not a pharmacy cash price — information only, not medical advice.

Source:CMS Medicare Part D Spending by Drug·as of calendar year 2024updated yearly (last: )
Not medical advice. This information is drawn unchanged from a public US government dataset for general information only. It is not a price quote and not a substitute for professional advice. Real prices vary by pharmacy, insurance, manufacturer and region. Always consult a licensed pharmacist or clinician before making any decision about your medication.

Highest and lowest cost per dosage unit

Highest avg Medicare Part D spending per dosage unit — calendar year 2024
DrugGenericPer dosage unit
MounjaroTirzepatide$511.63
TrulicityDulaglutide$467.75
OzempicSemaglutide$306.48
ShingrixVaricella-Zoster Ge/As01b/PF$196.56
JardianceEmpagliflozin$18.94
Lowest avg Medicare Part D spending per dosage unit — calendar year 2024
DrugGenericPer dosage unit
Metformin HClMetformin HCl$0.0564
HydrochlorothiazideHydrochlorothiazide$0.0584
Metoprolol TartrateMetoprolol Tartrate$0.0591
Metformin HCl ERMetformin HCl$0.06
CarvedilolCarvedilol$0.065

Most-claimed Part D drugs (2024)

Top 10 Medicare Part D drugs by 2024 claim volume
DrugGeneric2024 claimsPer dosage unit
Atorvastatin CalciumAtorvastatin Calcium73,349,032$0.1452
Amlodipine BesylateAmlodipine Besylate50,204,110$0.0848
Levothyroxine SodiumLevothyroxine Sodium43,253,940$0.1694
GabapentinGabapentin36,804,628$0.1192
LisinoprilLisinopril36,247,459$0.0889
Losartan PotassiumLosartan Potassium36,240,406$0.1256
Metoprolol SuccinateMetoprolol Succinate32,213,092$0.1825
Rosuvastatin CalciumRosuvastatin Calcium30,813,501$0.1872
OmeprazoleOmeprazole28,883,231$0.1716
Pantoprazole SodiumPantoprazole Sodium25,600,657$0.1987

Look up a drug's average Medicare cost

Search any of the 100 highest-volume Medicare Part D drugs by brand or generic name to see its real average spending per dosage unit and 2024 claim volume.

Every drug in this dataset

Frequently asked questions

What does the price on these pages mean?
It is the average Medicare Part D spending per dosage unit in 2024, weighted by claim volume across all manufacturers (the CMS field Avg_Spnd_Per_Dsg_Unt_Wghtd_2024). A "dosage unit" is one billing unit of the drug — for example one tablet, one millilitre or one gram, as defined by CMS. It is NOT the cash or retail price a patient pays at a pharmacy, NOT a per-prescription or per-package cost, and figures reflect Medicare Part D (older or disabled US beneficiaries) only. All figures are in US dollars.
Which drugs are covered, and for what year?
These 100 pages cover the 100 highest-volume Medicare Part D drugs by total 2024 claims, using calendar year 2024 figures from the CMS "Medicare Part D Spending by Drug" dataset (release year 2026). The most-claimed of these is Atorvastatin Calcium (Atorvastatin Calcium) with 73,349,032 Part D claims in 2024.
Which of these drugs cost the most and least per dosage unit?
By average Medicare Part D spending per dosage unit (calendar year 2024), the highest in this set is Mounjaro at $511.63 per dosage unit, and the lowest is Metformin HCl at $0.0564 per dosage unit. These are Medicare program spending figures, not pharmacy shelf prices, and a low per-unit figure does not mean a low total cost — total cost depends on how many units a prescription needs.
Is this medical or pricing advice?
No. This is information only, drawn unchanged from a public US government dataset. It is NOT medical advice and NOT a price quote. Real drug prices vary by pharmacy, insurance plan, manufacturer and region, and can differ greatly from Medicare program spending. Always consult a licensed pharmacist or clinician before making any decision about your medication.
Where does the data come from?
From the U.S. Centers for Medicare & Medicaid Services (CMS) "Medicare Part D Spending by Drug" dataset, release year 2026, data year 2024. It is a U.S. federal government work in the public domain. GeraClinic reports the CMS figures exactly as published and dates each one; we do not alter the numbers.

Questions about your medication?

A GeraClinic clinician can review your medication, explain options, and issue or renew a prescription where appropriate — online, without travelling to a clinic.

Contains public sector information published by U.S. Centers for Medicare & Medicaid Services (CMS) and licensed under the U.S. Government Works / Public Domain. Source: CMS Medicare Part D Spending by Drug (calendar year 2024, published 2026-06-25).

Informational/educational only — not a substitute for professional medical advice; a clinician interprets results.